CompletedNot Applicable

Benefits of Universal Glove and Gowning

United States19,856 participantsStarted 2010-12

Plain-language summary

This study will test if doctors, nurses and other people who take care of patients in hospitals wearing gloves and gown for all contact with patients in an intensive care unit (ICU) will: * Decrease the chance of patients getting an infection while in the hospital * Decrease the chance of patients picking up bacteria as a result of being in the hospital * Decrease the time a patient spends in the ICU or in the hospital * Increase the frequency of adverse events The study will also look at whether making doctors, nurses and other people who take care of patients wear gloves and gown for all contact with patients will decrease the amount of time healthcare workers spend with patients. This study will gather information by comparing what happens in ICUs that continue to do what they were doing before the study with what happens in ICUs that require healthcare workers to wear gloves and gown for all contact with patients. This study will provide information that will help to make being in the hospital safer for all patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: ICUs to be included are: adult medical, surgical or combined medical surgical ICU as defined below: * Medical ICU (MICU) \> 80% of patients have a medical condition and have not undergone a surgical procedure during the current hospital stay * Surgical ICU (SICU) \> 80% of the patients have undergone a surgical procedure during the current hospital stay * Combined Medical/Surgical ICU (MICU/SICU) - a roughly equivalent mixture of patients with medical conditions who have not undergone surgical procedures and patients who have undergone surgical procedures during the current hospital stay. Each group makes up \> 20% and less than 80% of the total number of patients * Ability to collect the data required for analysis * Written approval of the study from the institution's IRB. The institution may opt to use the IRB approval provided by the centralized IRB at the University of Maryland, School of Medicine * Memorandum of Understanding signed by the ICU Medical Director, ICU Nurse Manager or Director and the Hospital Epidemiologist indicating a commitment to supporting enrollment of an ICU and completion the study * Ability to be matched with another ICU based on baseline acquisition of resistant bacteria on culture * Agreement to not perform active surveillance for MRSA or VRE that will be fed back to patients during the study period Exclusion Criteria: Pediatric ICUs and other non-medical or non-surgical ICUs will be excluded

What they're measuring

Number of ICU Patients Who Acquire VRE or MRSA

Timeframe: 9 months

Trial details

NCT IDNCT01318213

SponsorUniversity of Maryland, Baltimore

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-10-04